Venture Capital and the European Biotechnology Industry

en Limba Engleză Paperback – 2009

This book opens up the world on private equity investment in one of the hottest industries – Biotechnology. The book describes how Europe has fallen behind the US due to under-investment and bad management by the VCs who control the companies. Detailed analysis shows why it is in VCs' interests to damage the very companies they invest in.

Citește tot Restrânge

Toate formatele și edițiile

	Preț	Express
Paperback (1)	623^.26 lei 6-8 săpt.
Palgrave Macmillan UK – 2009	623^.26 lei 6-8 săpt.
Hardback (1)	626^.33 lei 6-8 săpt.
Palgrave Macmillan UK – 20 noi 2008	626^.33 lei 6-8 săpt.

Preț: 623^.26 lei

Preț vechi: 733^.25 lei
-15% Nou

Puncte Express: 935

:
119^.41€ • 125^.72$ • 98^.56£

Carte tipărită la comandă

Livrare economică 22 ianuarie-05 februarie 25

Adaugă în coș

Wish list
Gift list
Am citit!

Adaugă în listă

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781349303816
ISBN-10: 134930381X
Pagini: 220
Ilustrații: VIII, 220 p.
Dimensiuni: 140 x 216 mm
Greutate: 0.3 kg
Ediția:1st ed. 2009
Editura: Palgrave Macmillan UK
Colecția Palgrave Macmillan
Locul publicării:London, United Kingdom

Cuprins

Introduction: The Facts The Biotechnology Industry and Venture Capital Europe Falls Behind Why Does Europe Do So Poorly? Some Inadequate Explanations Under-investment In European Biotechnology Public Markets and Under-investment VC Management of Companies VC Effects on Business Efficacy Investor Blockade of Business Pomp and Circumstances The Real VC Business Model What to do about it: Government What to do about it: Business References Index

Recenzii

'With this well-referenced book Dr Bains has filled an important lacuna within the literature on European biotech VC [venture capital] financing with an accessible primer for MBA students particularly those researching biopharma and VC business cases and for students undertaking specialist, industry-focused, post-graduate courses.' Gerhard Symons, Pharmaceutical Executive Europe

Notă biografică

WILLIAM BAINS is an academic and entrepreneur with experience in research, company creation and venture capital. He has founded four biotechnology companies, helped found and finance another ten, and is internationally recognized both as
an innovator in biotechnology and a translator of innovation into business. He has written over 100 papers and teaches on innovation and entrepreneurship at Cambridge University, UK.

Papetărie, jocuri, reviste